Robert Besthof

Insider Reports History

Entity
Individual
Location
1201 North Market Street, Suite 111, Wilmington, DE
Signature
/s/ Robert Besthof
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Besthof:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NRX Pharmaceuticals, Inc. Interim CEO Employee Stock Option (Right to buy) 247K $49.4K $0.20 Aug 16, 2021 Direct
NRX Pharmaceuticals, Inc. Interim CEO Common Stock 23.7K $7.58K $0.32 Sep 15, 2021 Direct
NRX Pharmaceuticals, Inc. Interim CEO Employee Stock Option 347K Mar 8, 2022 Direct
NRX Pharmaceuticals, Inc. Interim CEO Restricted Stock Units 36.3K Aug 16, 2021 Direct

Insider Reports Filed by Robert Besthof

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NRXP NRX Pharmaceuticals, Inc. Mar 8, 2022 1 $261K 4 Mar 10, 2022 Interim CEO
NRXP NRX Pharmaceuticals, Inc. Aug 16, 2021 4 -$478K 4 Nov 2, 2021 Chief Comm. & Patient Officer
NRXP NRX Pharmaceuticals, Inc. May 24, 2021 2 $0 4 Jun 10, 2021 Chief Comm. & Patient Officer
NRXP NRX Pharmaceuticals, Inc. May 24, 2021 0 $0 3 Jun 10, 2021 Chief Comm. & Patient Officer